Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Miiskin Opens Skin Tracking Platform to Dermatology Research
Digital skin health platform Miiskin has opened its technology to give academic researchers free access – supporting […]
Exosome-based Company Raised 5 M€ for the Development of Its New Biomedicine and Vaccines
Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that […]
NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets
NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech […]
HCS Pharma Expects 90% Success Rate on Cancer Drugs Tests Due to Recreation of Organs In-vitro with BIOMIMESYS® Technology
Cancer is the second cause of death in the world and has been steadily increasing […]
Cannabotech's "Integrative-Colon" Products Eliminated Over 90% of Colon Cancer Cells in a Cell Model Experiment
Cannabotech, a biomedical company developing oncological products based on cannabis and mushroom extracts, reports cell […]
Genetic Study Gives Extensive Insights into Severe Covid-19
The world’s largest study of the genetics of critical Covid-19, involving more than 57,000 people, […]
Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON™
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, […]
Immunovia Further Strengthens IP Portfolio for its IMMray ™ PanCan-d Signature
Immunovia AB (publ) announced today that the United States Patent and Trademark Office (USPTO) has […]
European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease
The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a […]
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more